[HTML][HTML] LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance

X Zhai, Z Xia, G Du, X Zhang, T Xia, D Ma, X Li, B Jin… - Genes & …, 2023 - Elsevier
Accumulating evidence supports the association of somatic mutations with tumor occurrence
and development. We aimed to identify somatic mutations with important implications in …

[PDF][PDF] LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance

X Zhai, Z Xia, G Du, X Zhang, T Xia, D Ma, X Li, B Jin… - 2022 - jps1.kxsz.net
Accumulating evidence supports the association of somatic mutations with tumor occurrence
and development. We aimed to identify somatic mutations with important implications in …

[PDF][PDF] LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance

X Zhaia, Z Xiab, G Dua, X Zhangc, T Xiad, D Mad, X Lie… - researchgate.net
Accumulating evidence supports the association of somatic mutations with tumor occurrence
and development. We aimed to identify somatic mutations with important implications in …

[HTML][HTML] LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance

X Zhai, Z Xia, G Du, X Zhang, T Xia, D Ma, X Li… - Genes & …, 2023 - ncbi.nlm.nih.gov
Accumulating evidence supports the association of somatic mutations with tumor occurrence
and development. We aimed to identify somatic mutations with important implications in …

LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance

X Zhai, Z Xia, G Du, X Zhang, T Xia, D Ma, X Li, B Jin… - genesndiseases.com
Accumulating evidence supports the association of somatic mutations with tumor occurrence
and development. We aimed to identify somatic mutations with important implications in …

[PDF][PDF] LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance

X Zhai, Z Xia, G Du, X Zhang, T Xia, D Ma, X Li, B Jin… - 2022 - scienceopen.com
Accumulating evidence supports the association of somatic mutations with tumor occurrence
and development. We aimed to identify somatic mutations with important implications in …

LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance

X Zhai, Z Xia, G Du, X Zhang, T Xia, D Ma, X Li… - Genes & …, 2023 - sciopen.com
LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects
doxorubicin resistance EN LOGIN REGISTER All data generated by the account on the …

LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance

X Zhai, Z Xia, G Du, X Zhang, T Xia, D Ma… - Genes & …, 2022 - pubmed.ncbi.nlm.nih.gov
Accumulating evidence supports the association of somatic mutations with tumor occurrence
and development. We aimed to identify somatic mutations with important implications in …

LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance.

X Zhai, Z Xia, G Du, X Zhang, T Xia, D Ma, X Li… - Genes & …, 2022 - europepmc.org
Accumulating evidence supports the association of somatic mutations with tumor occurrence
and development. We aimed to identify somatic mutations with important implications in …

[PDF][PDF] LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance

X Zhai, Z Xia, G Du, X Zhang, T Xia, D Ma, X Li, B Jin… - 2022 - jps1.kxsz.net
Accumulating evidence supports the association of somatic mutations with tumor occurrence
and development. We aimed to identify somatic mutations with important implications in …